In his testimony this week, Kennedy claimed that infectious diseases receive far more federal funding than chronic diseases.

The TSX parent reported adjusted earnings per share of 48 cents, topping the Street’s expectation by 4 cents as organic ...

Here are five key things investors need to know to start the trading day: 1. Tariff turbulence. U.S. stocks dropped on Monday ...

Vaccine specialist Valneva has ... over 50 million women in China from certain HPV-related cancers and diseases since its first approval, Merck’s president of Human Health International, Joseph ...

Merck’s stock tumbled 6% early Tuesday, after the drug company’s softer-than-expected guidance for the current year offset ...

Merck’s full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...

Merck (NYSE: MRK) recently released its Q4 results, with revenues and earnings exceeding the street estimates.

Merck (MRK) stock tumbles as slowing China sales for its HPV prevention drug ... the decision to temporarily halt shipments of Gardasil vaccines to China has affected its 2025 sales forecast.

As more cancers are being linked to the human papillomavirus (HPV), including cancers showing up in younger-than-average patients, a local doctor is promoting the use of the HPV vaccine, which is ...

Merck ( MRK) reported fourth quarter and full year earnings Tuesday, in line with Wall Street estimates. The bad news: Its ...